Lise Queiroz
Lausanne Branch
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.
Journal: Cell reports. Medicine
Published: September 23, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma.
Journal: Immunity
Published: August 18, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
Journal: Cell reports methods
Published: October 17, 2022
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes.
Journal: Cell systems
Published: June 23, 2022
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Journal: Nature communications
Published: June 21, 2022
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
Journal: International journal of cancer
Published: February 19, 2019
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
Journal: International journal of cancer
Published: January 08, 2016
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 18, 2015
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.
Journal: Cancer research
Published: September 08, 2015
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 20, 2015
Last Updated: 09/26/2026